Table 1.
Prognostic Factors | MSKCC Motzer et al,11 2002 |
IMDC Heng et al,13 2009 |
GFI Negrier et al,15 2002 |
CCF Mekhail et al,12 2005 |
IKCWG Manola et al,16 2011 |
---|---|---|---|---|---|
Performance status | ● | ● | ● | ● | |
Elevated serum LDH | ● | ● | ● | ||
Low hemoglobin | ● | ● | ● | ● | ● |
High corrected serum Ca | ● | ● | ● | ● | |
Time from Dx to Tx <1 y | ● | ● | ● ○ | ● | ● |
Prior radiotherapy | ● | ||||
Number of metastatic sites | ● ○ | ● | ● | ||
Hepatic metastasis | ○ | ||||
Elevated ANC | ● | ○ | ● (WBC) | ||
Elevated platelets | ● | ||||
Inflammation | ● | ||||
Elevated ALP | ● | ||||
Prior immunotherapy | ● |
Abbreviations: ●, prognostic factors for survival; ○, prognostic factors for rapid progression; ALP, alkaline phosphatase; ANC, absolute neutrophil count; Dx, diagnosis; GFI, Groupe Français d’Immunothérapie; Tx, therapy; WBC, white blood cells.